These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 30419304)

  • 1. Neurostimulation in dry eye disease-past, present, and future.
    Dieckmann G; Fregni F; Hamrah P
    Ocul Surf; 2019 Jan; 17(1):20-27. PubMed ID: 30419304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurostimulation for tear production.
    Park JK; Cremers S; Kossler AL
    Curr Opin Ophthalmol; 2019 Sep; 30(5):386-394. PubMed ID: 31393326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials.
    Sheppard JD; Torkildsen GL; Geffin JA; Dao J; Evans DG; Ousler GW; Wilson J; Baba SN; Senchyna M; Holland EJ
    Ocul Surf; 2019 Jan; 17(1):142-150. PubMed ID: 30472141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized, Controlled, Double-Masked, Multicenter, Pilot Study Evaluating Safety and Efficacy of Intranasal Neurostimulation for Dry Eye Disease.
    Cohn GS; Corbett D; Tenen A; Coroneo M; McAlister J; Craig JP; Gray T; Kent D; Murray N; Petsoglou C; Baba SN; Holland EJ
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):147-153. PubMed ID: 30629728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurostimulation for dry eye disease.
    Erdinest N; Pincovich S; London N; Solomon A
    Curr Opin Allergy Clin Immunol; 2022 Oct; 22(5):328-334. PubMed ID: 35779066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of non-invasive intranasal neurostimulation on tear volume, dryness and ocular pain.
    Farhangi M; Cheng AM; Baksh B; Sarantopoulos CD; Felix ER; Levitt RC; Galor A
    Br J Ophthalmol; 2020 Sep; 104(9):1310-1316. PubMed ID: 31831506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Tearing by Electrical Stimulation of the Anterior Ethmoid Nerve.
    Brinton M; Kossler AL; Patel ZM; Loudin J; Franke M; Ta CN; Palanker D
    Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2341-2348. PubMed ID: 28431436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Tear Neurostimulation: An Emerging Concept in the Treatment of Dry Eye.
    Gumus K; Pflugfelder SC
    Int Ophthalmol Clin; 2017; 57(2):101-108. PubMed ID: 28282317
    [No Abstract]   [Full Text] [Related]  

  • 9. Tear Proteomics Approach to Monitoring Sjögren Syndrome or Dry Eye Disease.
    Kuo MT; Fang PC; Chao TL; Chen A; Lai YH; Huang YT; Tseng CY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varenicline Solution Nasal Spray: A Review in Dry Eye Disease.
    Frampton JE
    Drugs; 2022 Sep; 82(14):1481-1488. PubMed ID: 36197638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel current and future therapy options for treatment of dry eye disease].
    Messmer EM
    Ophthalmologe; 2018 Feb; 115(2):100-106. PubMed ID: 29134276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Nano-ophthalmology in Treating Dry Eye Disease.
    Natesan S; Boddu SHS; Krishnaswami V; Shahwan M
    Pharm Nanotechnol; 2020; 8(4):258-289. PubMed ID: 32600244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in understanding and managing dry eye disease.
    Lemp MA
    Am J Ophthalmol; 2008 Sep; 146(3):350-356. PubMed ID: 18599017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
    Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
    Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tivanisiran, a novel siRNA for the treatment of dry eye disease.
    Moreno-Montañés J; Bleau AM; Jimenez AI
    Expert Opin Investig Drugs; 2018 Apr; 27(4):421-426. PubMed ID: 29569947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the tear film and ocular surface from dry eye syndrome.
    Johnson ME; Murphy PJ
    Prog Retin Eye Res; 2004 Jul; 23(4):449-74. PubMed ID: 15219877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rabbit models of dry eye disease: Current understanding and unmet needs for translational research.
    Singh S; Sharma S; Basu S
    Exp Eye Res; 2021 May; 206():108538. PubMed ID: 33771517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnosis and management of dry eye: a twenty-five-year review.
    Pflugfelder SC; Solomon A; Stern ME
    Cornea; 2000 Sep; 19(5):644-9. PubMed ID: 11009316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting.
    Baudouin C; Aragona P; Messmer EM; Tomlinson A; Calonge M; Boboridis KG; Akova YA; Geerling G; Labetoulle M; Rolando M
    Ocul Surf; 2013 Oct; 11(4):246-58. PubMed ID: 24112228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of dry eye disease].
    Jacobi C; Messmer EM
    Ophthalmologe; 2018 May; 115(5):433-450. PubMed ID: 29651548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.